抑制TRIM8通过调节DUSP14/MAPKs通路来缓解脂肪细胞炎症和胰岛素抵抗
Mingxue Zhu1, Junliang Pu1, Ting Zhang1
1Phase I Clinical Research Center, Bishan Hospital of Chongqing, Bishan Hospital of Chongqing Medical University, Chongqing, China.
Adipocyte
|July 23, 2024
概括
肥胖症涉及脂肪细胞的慢性炎症,导致代谢疾病. 这项研究表明,TRIM8和DUSP14通过影响MAPKs通路来调节这种炎症并改善胰岛素抵抗.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 代谢疾病 代谢疾病
背景情况:
- 肥胖症的特点是脂肪细胞的慢性低度炎症,导致2型糖尿病和NAFLD等代谢障碍.
- 控制脂肪细胞炎症和胰岛素抵抗的精确分子机制尚未完全理解.
- TRIM8和DUSP14被确定为脂肪细胞炎症过程中的关键调节剂.
研究的目的:
- 研究TRIM8和DUSP14在调节脂肪细胞炎症和胰岛素抵抗中的作用.
- 阐明TRIM8和DUSP14影响炎症路径和胰岛素信号的分子机制.
- 在代谢功能障碍的背景下,确定TRIM8,DUSP14和MAPKs途径之间的关系.
主要方法:
- 利用脂肪细胞炎症和胰岛素抵抗的细胞模型.
- 通过缺乏和过度表达操纵TRIM8和DUSP14的表达.
- 评估了炎症性细胞因子水平,葡萄糖吸收和胰岛素信号通路酸化.
- 研究了MAPKs途径在TRIM8和DUSP14中介作用中的参与.
主要成果:
- 在具有胰岛素抵抗性的炎症脂肪细胞中,TRIM8被上调,而DUSP14被下调.
- TRIM8缺乏或DUSP14过度表达减少了炎症性细胞因子,改善了葡萄糖吸收和胰岛素信号传递.
- DUSP14沉默导致炎症加剧,葡萄糖吸收减少,胰岛素信号受损.
- 由于DUSP14下调,TRIM8缺陷的保护作用被逆转,这表明了依赖性.
结论:
- 在调节脂肪细胞炎症和胰岛素抵抗方面,TRIM8和DUSP14起着关键的,相反的作用.
- 通过对MAPKs通路的DUSP14依赖调节,TRIM8影响脂肪细胞炎症和胰岛素抵抗.
- 这些发现为与肥胖相关的代谢疾病提供了潜在的治疗点.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
01:23Dipeptidyl Peptidase 4 Inhibitors
180
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
180
01:20The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
01:28Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
01:25cAMP-dependent Protein Kinase Pathways
6.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.2K